Wallace Brownlee talks about his group’s findings that conventional MRI measures of inflammatory disease could help identify patients with early multiple sclerosis who are at high risk of developing cognitive disability (3:05).

Funding for this video was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.